Hamilton Lane Advisors LLC Esperion Therapeutics, Inc. Transaction History

Hamilton Lane Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$11.34 - $21.37 $134,503 - $253,469	-11,861 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$19.4 - $28.71 $182,204 - $269,644	-9,392 Reduced 44.19%	11,861 $251,000
Q1 2021 May 05, 2021	SELL	$25.12 - $36.89 $626,191 - $919,593	-24,928 Reduced 53.98%	21,253 $596,000
Q1 2020 Apr 27, 2020	SELL	$27.44 - $73.84 $182,338 - $490,666	-6,645 Reduced 12.58%	46,181 $1.46 Million
Q1 2019 Apr 22, 2019	BUY	$40.11 - $53.57 $1.25 Million - $1.67 Million	31,264 Added 145.0%	52,826 $2.12 Million
Q2 2018 Jul 31, 2018	SELL	$36.2 - $76.4 $362,000 - $764,000	-10,000 Reduced 31.68%	21,562 $1,000
Q1 2018 May 03, 2018	SELL	$65.94 - $80.76 $5.52 Million - $6.77 Million	-83,782 Reduced 72.64%	31,562 $2,000
Q4 2017 Jan 17, 2018	BUY	$43.47 - $67.43 $5.01 Million - $7.78 Million	115,344	115,344 $7.59 Million

197

136M

2.72M

1.3M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $136M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.